These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 231845)

  • 1. Response of the secretory immune system to bronchogenic carcinoma of the lung.
    Iglehart JD; Montelaro RC; Bolognesi DP; Sabiston DC; Wolfe WG
    Surg Forum; 1979; 30():118-9. PubMed ID: 231845
    [No Abstract]   [Full Text] [Related]  

  • 2. Function of the secretory immune system in bronchogenic carcinoma. Immunoglobulin A levels in respiratory secretions.
    Iglehart JD; Warzynski MJ; Montelaro RC; Bolognesi DP; Sabiston DC; Wolfe WG
    J Thorac Cardiovasc Surg; 1981 Jul; 82(1):63-9. PubMed ID: 7242134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory IgA content in human normal and tumoral bronchial mucosa in vitro.
    de Lustig ES; Matos E; Spector C; Scheitman B; Diaz A
    Oncology; 1980; 37(1):16-9. PubMed ID: 7350548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of secretory immunoglobulin A, IgG and IgM in bronchial lavage from patients with primary and metastatic lung neoplasms ].
    Viramontes L; Cicero R; Acosta G; Barragan L; Orozco R; Torres S
    Arch Invest Med (Mex); 1989; 20(2):175-81. PubMed ID: 2604502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome in bronchogenic carcinoma: report of two cases with immunochemical studies.
    da Costa CR; Dupont E; Hamers R; Hooghe R; Dupuis E; Potvliege R
    Clin Nephrol; 1974; 2(6):245-51. PubMed ID: 4614928
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody in sera of pulmonary cancer patients against specific surface antigen of oat cells.
    Oboshi S; Seido T; Tsugawa S
    Gan; 1971 Dec; 62(6):515-22. PubMed ID: 4334635
    [No Abstract]   [Full Text] [Related]  

  • 7. [Circulating immunocomplexes in lung neoplasms].
    Pesek M; Sefrna F; Simecek C; Racek J
    Vnitr Lek; 1982 Jun; 28(6):571-6. PubMed ID: 6287725
    [No Abstract]   [Full Text] [Related]  

  • 8. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
    Takita H; Brugarolas A
    J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
    [No Abstract]   [Full Text] [Related]  

  • 10. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum immunoglobulin abnormalities in patients with respiratory tract disease.
    Nash DR
    Ann Clin Res; 1979 Apr; 11(2):49-52. PubMed ID: 453780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of isoantigens A, B, and H in carcinoma of the lung.
    Davidsohn I; Ni LY
    Am J Pathol; 1969 Nov; 57(2):307-34. PubMed ID: 4902573
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical markers in bronchogenic carcinoma.
    Coombes RC; Ellison ML; Neville AM
    Br J Dis Chest; 1978 Oct; 72(4):263-87. PubMed ID: 215186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunomorphology of lymph nodes and prognosis in lung cancer].
    Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
    Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for immunotherapy in small cell bronchogenic carcinoma?
    Israel L
    Recent Results Cancer Res; 1985; 97():157-61. PubMed ID: 2986242
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
    Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
    Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in bronchogenic carcinoma.
    Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
    Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panel report. Radiotherapy for lung cancer.
    Rubin P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):311-5. PubMed ID: 4729336
    [No Abstract]   [Full Text] [Related]  

  • 20. [The major histocompatibility system in bronchogenic carcinoma].
    Mĕricka O; Zatloukal P; Prazák J
    Sb Lek; 1988 Oct; 90(10):314-7. PubMed ID: 3206172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.